Published in J Neurosci Methods on September 02, 2007
Automatic Recognition of Freezing of Gait Episodes | NCT00738075
Gait analysis using wearable sensors. Sensors (Basel) (2012) 2.90
Knee trembling during freezing of gait represents multiple anticipatory postural adjustments. Exp Neurol (2008) 1.73
Functional reorganization of the locomotor network in Parkinson patients with freezing of gait. PLoS One (2014) 1.17
Objective biomarkers of balance and gait for Parkinson's disease using body-worn sensors. Mov Disord (2013) 1.15
Autonomous identification of freezing of gait in Parkinson's disease from lower-body segmental accelerometry. J Neuroeng Rehabil (2013) 1.07
Normal and pathological gait: what we learn from Parkinson's disease. J Neurol Neurosurg Psychiatry (2012) 1.04
Real-time gait cycle parameter recognition using a wearable accelerometry system. Sensors (Basel) (2011) 1.01
Validation of 24-hour ambulatory gait assessment in Parkinson's disease with simultaneous video observation. Biomed Eng Online (2011) 1.00
Wearable accelerometry-based technology capable of assessing functional activities in neurological populations in community settings: a systematic review. J Neuroeng Rehabil (2014) 0.99
Unbiased and mobile gait analysis detects motor impairment in Parkinson's disease. PLoS One (2013) 0.99
Quantifying freezing of gait in Parkinson's disease during the instrumented timed up and go test. Conf Proc IEEE Eng Med Biol Soc (2012) 0.97
Detection of freezing of gait in Parkinson disease: preliminary results. Sensors (Basel) (2014) 0.97
Framework for understanding balance dysfunction in Parkinson's disease. Mov Disord (2013) 0.96
Cognitive Contributions to Freezing of Gait in Parkinson Disease: Implications for Physical Rehabilitation. Phys Ther (2015) 0.92
Feature extraction and selection for objective gait analysis and fall risk assessment by accelerometry. Biomed Eng Online (2011) 0.91
Is freezing of gait in Parkinson's disease a result of multiple gait impairments? Implications for treatment. Parkinsons Dis (2012) 0.90
Development and testing of a self administered version of the Freezing of Gait Questionnaire. BMC Neurol (2010) 0.89
Position and orientation tracking in a ubiquitous monitoring system for Parkinson disease patients with freezing of gait symptom. JMIR Mhealth Uhealth (2013) 0.85
Variability of Stepping during a Virtual Reality Paradigm in Parkinson's Disease Patients with and without Freezing of Gait. PLoS One (2013) 0.83
The Neuro-Mechanical Processes That Underlie Goal-Directed Medio-Lateral APA during Gait Initiation. Front Hum Neurosci (2016) 0.80
Heart rate changes during freezing of gait in patients with Parkinson's disease. Mov Disord (2010) 0.79
The Clinical Significance Of Freezing While Turning in Parkinson's Disease. Neuroscience (2016) 0.79
Noisy interlimb coordination can be a main cause of freezing of gait in patients with little to no parkinsonism. PLoS One (2013) 0.78
Amplitude Manipulation Evokes Upper Limb Freezing during Handwriting in Patients with Parkinson's Disease with Freezing of Gait. PLoS One (2015) 0.78
Towards Real-Time Detection of Freezing of Gait Using Wavelet Transform on Wireless Accelerometer Data. Sensors (Basel) (2016) 0.78
Effects of Sensitive Electrical Stimulation Based Cueing in Parkinson's Disease: A Preliminary Study. Eur J Transl Myol (2016) 0.77
Temporal Characteristics of High-Frequency Lower-Limb Oscillation during Freezing of Gait in Parkinson's Disease. Parkinsons Dis (2014) 0.76
Real-Time Classification of Patients with Balance Disorders vs. Normal Subjects Using a Low-Cost Small Wireless Wearable Gait Sensor. Biosensors (Basel) (2016) 0.75
Estimation of Temporal Gait Parameters Using a Wearable Microphone-Sensor-Based System. Sensors (Basel) (2016) 0.75
German translation and validation of the "freezing of gait questionnaire" in patients with Parkinson's disease. Parkinsons Dis (2015) 0.75
A practical method for the detection of freezing of gait in patients with Parkinson's disease. Clin Interv Aging (2014) 0.75
Freezing of Gait in Parkinsonism and its Potential Drug Treatment. Curr Neuropharmacol (2016) 0.75
Home detection of freezing of gait using support vector machines through a single waist-worn triaxial accelerometer. PLoS One (2017) 0.75
The Practicalities of Assessing Freezing of Gait. J Parkinsons Dis (2016) 0.75
Assessing Motor Fluctuations in Parkinson's Disease Patients Based on a Single Inertial Sensor. Sensors (Basel) (2016) 0.75
Technologies for Assessment of Motor Disorders in Parkinson's Disease: A Review. Sensors (Basel) (2015) 0.75
Non-human primate FOG develops with advanced parkinsonism induced by MPTP Treatment. Exp Neurol (2012) 0.75
Symmetry Analysis of Gait between Left and Right Limb Using Cross-Fuzzy Entropy. Comput Math Methods Med (2016) 0.75
Enabling breakthroughs in Parkinson's disease with wearable technologies and big data analytics. Mhealth (2016) 0.75
Freezing of gait and fall detection in Parkinson's disease using wearable sensors: a systematic review. J Neurol (2017) 0.75
Quantitative Analysis of Motor Status in Parkinson's Disease Using Wearable Devices: From Methodological Considerations to Problems in Clinical Applications. Parkinsons Dis (2017) 0.75
Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet (2003) 3.39
Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol (2011) 2.12
Long-term evaluation of deep brain stimulation of the thalamus. J Neurosurg (2006) 2.02
Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann Neurol (2003) 2.01
Effect of stimulus rise-time on the ocular vestibular-evoked myogenic potential to bone-conducted vibration. Ear Hear (2013) 1.98
Gentamicin ototoxicity: a 23-year selected case series of 103 patients. Med J Aust (2012) 1.61
Restless legs syndrome (RLS) augmentation associated with dopamine agonist and levodopa usage in a community sample. Sleep Med (2011) 1.57
Association studies of variants in MEIS1, BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US population. Sleep Med (2011) 1.53
Impulsive testing of semicircular-canal function using video-oculography. Ann N Y Acad Sci (2009) 1.31
Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet (2011) 1.27
Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord (2004) 1.26
Long-term monitoring of gait in Parkinson's disease. Gait Posture (2006) 1.25
Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease. Mov Disord (2009) 1.19
Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord (2007) 1.18
Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet (2004) 1.18
Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor. Mov Disord (2007) 1.17
Interruption management in the intensive care unit: Predicting resumption times and assessing distributed support. J Exp Psychol Appl (2010) 1.15
Cerebellar ataxia, neuropathy, vestibular areflexia syndrome (CANVAS): a review of the clinical features and video-oculographic diagnosis. Ann N Y Acad Sci (2011) 1.14
Locomotion is increased in a11-lesioned mice with iron deprivation: a possible animal model for restless legs syndrome. J Neuropathol Exp Neurol (2007) 1.14
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease. Mov Disord (2006) 1.12
Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature. Clin Ther (2012) 1.11
Autonomous identification of freezing of gait in Parkinson's disease from lower-body segmental accelerometry. J Neuroeng Rehabil (2013) 1.07
Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial. Parkinsonism Relat Disord (2008) 1.02
Vibration-induced ocular torsion and nystagmus after unilateral vestibular deafferentation. Brain (2003) 1.00
Increased melanoma risk in Parkinson disease: a prospective clinicopathological study. Arch Neurol (2010) 0.99
Changes in ocular torsion position produced by a single visual line rotating around the line of sight--visual "entrainment" of ocular torsion. Vision Res (2004) 0.99
Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States. Mov Disord (2010) 0.98
Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation. J Neurosci Res (2007) 0.98
Restless legs syndrome: pathophysiology, diagnosis and treatment. CNS Drugs (2008) 0.97
Modeling locomotor dysfunction following spaceflight with Galvanic vestibular stimulation. Exp Brain Res (2006) 0.95
Tetrabenazine for hyperglycemic-induced hemichorea-hemiballismus. Mov Disord (2006) 0.95
Cyclooxygenase-2 in the pathogenesis of murine cerebral malaria. J Infect Dis (2004) 0.95
Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. Arch Neurol (2003) 0.95
Brain magnetic resonance imaging (MRI) in parkinsonian disorders. Parkinsonism Relat Disord (2008) 0.95
Does the endogenous opiate system play a role in the Restless Legs Syndrome? A pilot post-mortem study. J Neurol Sci (2009) 0.94
Gabapentin enacarbil in restless legs syndrome: a phase 2b, 2-week, randomized, double-blind, placebo-controlled trial. Clin Neuropharmacol (2009) 0.94
A pilot study of the clinical efficacy and safety of memantine for Huntington's disease. Parkinsonism Relat Disord (2006) 0.93
Effects of Galvanic vestibular stimulation on cognitive function. Exp Brain Res (2011) 0.93
Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. Mayo Clin Proc (2013) 0.92
Family-based and population-based association studies validate PTPRD as a risk factor for restless legs syndrome. Mov Disord (2011) 0.91
Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomy. Neurosurgery (2003) 0.91
Effects of head-down bed rest and artificial gravity on spatial orientation. Exp Brain Res (2010) 0.89
Locomotor response to levodopa in fluctuating Parkinson's disease. Exp Brain Res (2007) 0.88
Benefits and risks of pharmacological treatments for essential tremor. Drug Saf (2003) 0.88
Galvanic vestibular stimulation as an analogue of spatial disorientation after spaceflight. Aviat Space Environ Med (2011) 0.87
Stereotypies as a manifestation of acute hyperglycemia without ketosis. J Neurol Sci (2011) 0.86
Objective verification of full recovery of dynamic vestibular function after superior vestibular neuritis. Laryngoscope (2011) 0.86
Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations. Arch Neurol (2006) 0.86
New, fast, clinical vestibular tests identify whether a vertigo attack is due to early Ménière's disease or vestibular neuritis. Laryngoscope (2012) 0.85
Effect of tetrabenazine on computerized dynamic posturography in Huntington disease patients. Parkinsonism Relat Disord (2012) 0.85
Thalamic deep brain stimulation for orthostatic tremor. Tremor Other Hyperkinet Mov (N Y) (2011) 0.84
What does the dissociation between the results of video head impulse versus caloric testing reveal about the vestibular dysfunction in Ménière's disease? Acta Otolaryngol (2015) 0.83
Treatment of fragile-X-associated tremor/ataxia syndrome with deep brain stimulation. Mov Disord (2009) 0.83
Pharmacological management of essential tremor. Drugs (2010) 0.83
G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy. Mov Disord (2007) 0.83
Rapid fluctuations in dynamic semicircular canal function in early Ménière's disease. Eur Arch Otorhinolaryngol (2010) 0.82
Dramatic response of facial stereotype/tic to tetrabenazine in the first reported cases of neuroferritinopathy in the United States. Mov Disord (2010) 0.82
The use of gabapentin enacarbil in the treatment of restless legs syndrome. Ther Adv Neurol Disord (2010) 0.81
Head-eye coordination during simulated orbiter landing. Aviat Space Environ Med (2008) 0.80
Vertical and horizontal eye movement responses to unilateral and bilateral bone conducted vibration to the mastoid. J Vestib Res (2009) 0.80
Neural basis of new clinical vestibular tests: otolithic neural responses to sound and vibration. Clin Exp Pharmacol Physiol (2014) 0.80
Enhanced otolithic function in semicircular canal dehiscence. Acta Otolaryngol (2010) 0.79
Tolerance to extended galvanic vestibular stimulation: optimal exposure for astronaut training. Aviat Space Environ Med (2011) 0.79
The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model. Sleep Med (2010) 0.79
Electrotactile feedback of sway position improves postural performance during galvanic vestibular stimulation. Ann N Y Acad Sci (2009) 0.77
Placebo response in Parkinson trials using patient diaries: sites do matter. Clin Neuropharmacol (2007) 0.77
Eye velocity asymmetry, ocular orientation, and convergence induced by angular rotation in the rabbit. Vision Res (2005) 0.77
Unilateral vestibular loss due to systemically administered gentamicin. Otol Neurotol (2011) 0.76
Dextromethorphan/quinidine for chorea: an open-label assessment. Clin Neuropharmacol (2012) 0.76
Open-label study assessment of safety and adverse effects of subcutaneous apomorphine injections in treating "off" episodes in advanced Parkinson disease. Clin Neuropharmacol (2009) 0.76
Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs. J Neurol Sci (2008) 0.76
Task-specific focal hand dystonia in a professional pistol-shooter. Clin Neurol Neurosurg (2008) 0.76
Does idiopathic restless legs syndrome delay onset and reduce severity of Parkinson's disease: a pilot study. Int J Neurosci (2014) 0.76
A pilot study: Microlesion effects and tremor outcome in the ventrointermediate deep brain stimulation (VIM-DBS). Clin Neurol Neurosurg (2010) 0.76
Long-term efficacy of rasagiline in early Parkinson's disease. Int J Neurosci (2010) 0.76
What does the head impulse test versus caloric dissociation reveal about vestibular dysfunction in Ménière's disease? Ann N Y Acad Sci (2015) 0.76
Basal ganglia neuronal discharge in primary and secondary dystonia. Adv Neurol (2004) 0.76
Bone conducted vibration to the mastoid produces horizontal, vertical and torsional eye movements. J Vestib Res (2015) 0.75
Animal studies in restless legs syndrome. Mov Disord (2007) 0.75
Superior canal dehiscence reveals concomitant unilateral utricular loss (UUL). Acta Otolaryngol (2015) 0.75
Effect of tetrabenazine use on restless legs syndrome. Sleep Med (2010) 0.75
Cognitive demand affects the gain of the torsional optokinetic response. Exp Brain Res (2004) 0.75
Levodopa-induced dyskinesias in spinocerebellar ataxia type 2. Arch Neurol (2010) 0.75